NCT00978588CompletedNot Applicable
Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Yonsei University
- Enrollment
- 36
- Primary Endpoint
- the pure effect of priming solutions
Study Overview
Brief Summary
Comparison of 6% hydroxyethyl starch 130/0.4 with 5% albumin as priming solution for cardiopulmonary bypass
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Mitral valvular heart disease
Exclusion Criteria
- •Status of Infection
- •Re-operation
- •Liver failure
- •Renal disease
- •Administration of steroid
Arms & Interventions
HES 130/0.4
Experimental
Intervention: 6% hydroxyethyl starch 130/0.4 and 5% albumin (Drug)
5% albumin
Active Comparator
Intervention: 6% hydroxyethyl starch 130/0.4 and 5% albumin (Drug)
Outcomes
Primary Outcomes
the pure effect of priming solutions
Time Frame: after CPB
Secondary Outcomes
No secondary outcomes reported
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Comparison of Albumin 5%, Hydroxyethyl Starch 130/0.4 (6%) and Ringer Lactate for volume replacement during cardiac surgery - n/aIntensive care patients after cardiac surgery requiring volume therapyEUCTR2005-005040-85-ATDepartment of Anesthesia, Div. of Cardiothoracic and Vascular Anesthesia, Medical University Vienna240
Completed
Not Applicable
Comparison of Hydroxyethyl Starch and Crystalloid Coload Combined With Norepinephrine Infusion for HypotensionAdverse EffectNCT05475990General Hospital of Ningxia Medical University80
Completed
Not Applicable
Comparison of Different HES Coload Volumes on the 90% ED of NorepinephrineAdverse EffectNCT05712018General Hospital of Ningxia Medical University90
Active, not recruiting
Not Applicable
Comparison of 6% Hydroxyethyl Starch and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Elimination of the Bladder (CHART study)Comparison of 6% Hydroxyethyl Starch and 5% Albumin for Volume Replacement Therapy in Patients Undergoing CystectomyMedDRA version: 15.1Level: LLTClassification code 10021139Term: HypovolemiaSystem Organ Class: 100000004861EUCTR2010-018343-34-DEudwigs Maximilians University
Not yet recruiting
Unknown
Blood sugar levels during lower limb surgery under subarachnoid blockCTRI/2023/09/057477SMS Medical College
